MP Advisors (Mehta Partners)

MP Advisors exclusive focus and in-depth understanding of pharma Industry over two decades enables the team to offer advisory services to the pharmaceutical companies engaged in Innovation, manufacturing, formulation of drugs, CROs. Our services also extends to Corporate Investors like Private equities, Venture Capital and Angel Investors. Our proprietary database and acquired domain skills support us in advising Private equity/investors in understanding the risk reward of investing in the pharma sector across the globe-US, Europe, Japan and India. We integrate the teams knowledge and experience to understand the complex science, dynamic market environment shaped by the regulatory approval process to...

Merger & acquisitions,product in licensing,product out licensing,due deligence,product selection,feasibility study,strategic advisory,financial valuations,private equity investment,venture capital,angel investor,brand divestment,therapeutic class analysis,research,pharmaceutical and biotechnology consultant,market research,market analysis,competition analysis,and healthcare consulting

Mp advisors (mehta partners) operates in the Pharmaceutical manufacturing industry.

Mp advisors (mehta partners)'s revenue is 11m - 100m

Mp advisors (mehta partners) has 11 - 50 employees.